SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21523)5/28/1998 6:20:00 PM
From: Machaon  Read Replies (2) | Respond to of 32384
 
<< I think that LGND can do small trials >>

Could you elaborate on that? Would the timeline be shortened, once Panretin is approved for KS by the FDA, if LGND wants to test it on other cancers?

I realize that they don't have to do Phase I, but can they go directly to Phase III? And, as you indicated, can they do the testing on a small number of participants?

Thanks, Bob


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News